ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1748

Deep Immune Profiling of Cytotoxic T Cells (CTL) from Patients with Ankylosing Spondylitis Revealed a Subset of CTL Co-Expressing PD-1 and TIGIT That Resists Immune Exhaustion

Michael Tang1, Addison Pacheco2, Zoya Qaiyum3, Melissa Lim1 and Robert Inman1, 1University Health Network, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Krembil Research Institute, Toronto, ON, Canada

Meeting: ACR Convergence 2022

Keywords: Ankylosing spondylitis (AS), Biomarkers, Cytotoxic Cells, spondyloarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: T Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Unresolved, chronic inflammation is a key feature of Ankylosing Spondylitis (AS) yet the immunological events perpetuating remain unclear. The strongest genetic association with AS is HLA-B27, a class I MHC allele, suggesting involvement of CTLs in AS pathogenesis. To date, the CTL compartment contributing to AS inflammation has not been fully defined. In the context of chronic inflammation, CTL exhaustion (often characterized by PD-1/TIGIT upregulation) represents a hyporesponsive state that limits excess effector function, which would otherwise cause inflammatory immunopathologies. Here, we sought to define how CTL dysregulation drives chronic inflammatory response in AS patients.

Methods: We performed extensive immunophenotyping of PBMCs and synovial fluid (SF) MCs, focusing on CTLs, using a 30+ parameter mass cytometry time-of-flight (CyTOF) panel. CTL in vitro functional assays were performed to assess cytotoxic functions.

Results: PD-1 and TIGIT expressions on peripheral CTLs are significantly lower (Mean= 17.2/25.5% of CD8 expressing PD-1/TIGIT respectively) in AS patients with active disease (BASDAI > 5.0) compared to healthy controls (Mean= 27.1/43.4%). Contrarily, PD-1 and TIGIT were highly upregulated on CTLs from SF of AS patients, suggesting evidence of strong immune activation and possible immune exhaustion. Unsupervised clustering analysis of CyTOF data identified two subsets of CTLs that co-express PD-1 and TIGIT based on CD127 expression. The CD127- subset (terminally exhausted) from SF expressed higher levels of GZMB, perforin, and CD38 compared to CD127+ PD-1+ CTLs (memory-like). Contrary to the CD127- CTL subset from PBMC, which produced substantially less IFNγ and TNFα upon stimulation, the CD127- CTL subset from SF retained the capacity to produce both cytokines.

Conclusion: We report a subset of CTLs in SF of AS patients co-expressing classical exhaustion markers (PD-1 & TIGIT) with downregulated CD127 expression. These dysregulated CTLs are highly cytotoxic and potentially exacerbate chronic inflammation in AS.

Supporting image 1

Live CD45+ cells from single file representations of paired AS SFMC and PBMC (n=8) were entered into UMAP algorithm for high-dimensional analysis of immune checkpoint molecules. Heat-maps display expression levels of indicated surface molecules.


Disclosures: M. Tang, None; A. Pacheco, None; Z. Qaiyum, None; M. Lim, None; R. Inman, Novartis, Janssen, AbbVie/Abbott, Eli Lilly, Aria Pharmaceuticals, Amgen, Pfizer, Sandoz.

To cite this abstract in AMA style:

Tang M, Pacheco A, Qaiyum Z, Lim M, Inman R. Deep Immune Profiling of Cytotoxic T Cells (CTL) from Patients with Ankylosing Spondylitis Revealed a Subset of CTL Co-Expressing PD-1 and TIGIT That Resists Immune Exhaustion [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/deep-immune-profiling-of-cytotoxic-t-cells-ctl-from-patients-with-ankylosing-spondylitis-revealed-a-subset-of-ctl-co-expressing-pd-1-and-tigit-that-resists-immune-exhaustion/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deep-immune-profiling-of-cytotoxic-t-cells-ctl-from-patients-with-ankylosing-spondylitis-revealed-a-subset-of-ctl-co-expressing-pd-1-and-tigit-that-resists-immune-exhaustion/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology